SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, said on Thursday that it has continued to cut its debt, is on track with its plans to produce Johnson & Johnson’s (J&J’s) coronavirus vaccine and is committed to reintroducing dividends.

Aspen was among a host of companies that scrapped dividends last year as it sought to preserve cash amid the uncertainty created by the coronavirus pandemic...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now